Stock Price Quote

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01038Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE915.506.75 (+0.74 %)
PREV CLOSE ( ) 915.50
OPEN PRICE ( ) 911.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11531
TODAY'S LOW / HIGH ( )897.30 916.20
52 WK LOW / HIGH ( )831.4 1228.7
NSE915.005.6 (+0.62 %)
PREV CLOSE( ) 915.00
OPEN PRICE ( ) 905.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 915.00 (132)
VOLUME 193371
TODAY'S LOW / HIGH( ) 896.00 917.45
52 WK LOW / HIGH ( )831.05 1228.35
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-10 1949
Management Info
Premchand Godha - Chairman Premchand Godha - Managing Director
Registered Office

Address 48 , Kandivli Industrial Estate,Kandivli (West), ,
Mumbai,
Maharashtra-400067

Phone 022- 66474444/62106050

Email investors@ipca.com

Website www.ipca.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

04Aug Announcement under Regulation 30 (LOD
With profound grief, we have to inform you the sad and sudden demise of..
03Aug Ipca Laboratories informs about demise
Ipca Laboratories has informed about the sad and sudden demise of the In..
20May IPCA Laboratories informs about confer
In accordance with Regulation 30(6) of the SEBI (Listing Obligations and..
12May Ipca Laboratories informs about board
Ipca Laboratories has informed that the meeting of the Board of Director..
09Feb Ipca Laboratories informs about confer
In accordance with Regulation 30(6) of the SEBI (Listing Obligations and..

Financials

in Millions
QTR Jun 22 ANNUAL 22
Net Profit1438.28709.40000000001
Gross Profit 2160.6 10883.6
Operating Profit 2762.612996.7
Net Sales 14692.853993.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  3108.30 (3.58%)
M.Cap ( in Cr)7770.75
Procter&Gamble Healt (BSE)
peergroup  4090.40 (2.11%)
M.Cap ( in Cr)6789.81
RPG Life Sciences (BSE)
peergroup  807.80 (10.83%)
M.Cap ( in Cr)1336.02
Neuland Laboratories (BSE)
peergroup  1362.85 (5.36%)
M.Cap ( in Cr)1748.52
Medicamen Biotech (BSE)
peergroup  1025.50 (3.56%)
M.Cap ( in Cr)1297.37

Shareholding Pattern

NON-INSTITUTION 9.37%
PROMOTERS 46.29%
FI/BANKS/INSURANCE 3.9%
MUTUAL FUNDS/UTI 29.41%
GOVERNMENT 0.24%
FII 0%

About Ipca Laboratories Ltd.

Ipca Laboratories Ltd. was incorporated in the year 1949. Its today's share price is 915.5. Its current market capitalisation stands at Rs 23226.62 Cr. In the latest quarter, company has reported Gross Sales of Rs. 53993.6 Cr and Total Income of Rs.54785.6 Cr. The company's management includes Harish P Kamath, Kamal Kishore Seth, Manisha Premnath, Anand T Kusre, Prashant Godha, Pranay Godha, Ajit Kumar Jain, Premchand Godha, Premchand Godha.

It is listed on the BSE with a BSE Code of 524494 , NSE with an NSE Symbol of IPCALAB and ISIN of INE571A01038. It's Registered office is at 48 , Kandivli Industrial Estate,Kandivli (West), Mumbai-400067, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are GM Kapadia & Co, Natvarlal Vepari & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)